• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Steroid Profiles
  • Steroid Articles
    • Contributors
  • Steroid Forum
MESO-Rx

MESO-Rx

Anabolic Steroids

  • Anabolic Steroids
    • Anadrol
    • Anavar
    • Deca Durabolin
    • Dianabol
    • Equipoise
    • Masteron
    • Oral Turinabol
    • Primobolan Depot
    • Sustanon 250
    • Testosterone
    • Trenbolone Acetate
    • Winstrol Depot
  • hGH & Peptides
    • CJC-1295
    • GHRP-6
    • hGH
    • hCG
    • IGF-1
    • Melanotan II
    • MGF
    • Mod GRF 1-29
    • TB-500
  • Anti-Estrogens
    • Arimidex
    • Aromasin
    • Clomid
    • Letrozole
    • Nolvadex
  • Fat Loss
    • AICAR
    • Albuterol
    • Clenbuterol
    • DNP
    • Ephedrine
    • T3
    • Telmisartan
You are here: Home / Steroid News / Use of Biosimilar EPO Agents Widespread at 2008 Tour de France

Use of Biosimilar EPO Agents Widespread at 2008 Tour de France

July 21, 2008 by Millard Leave a Comment

Epogen - Erythropoietin EPO

A BBC investigation suggests that most athletes who use recombinant human erythropoietin (EPO) continue to get away with it. The investigative article reveals several reasons why the EPO test is failing. But the BBC revealed that the biggest problem is not the ineffectiveness of the existing EPO tests used by the World Anti-Doping Agency (WADA). It is a lack of testing for variants of EPO.

Athletes are using various “biosimilar” EPO agents for which WADA has not yet developed a detection method. WADA’s ballyhooed test for the previously undetectable Mircera (pegylated EPO) was an admission that the already flawed existing EPO test was unable to detect variants of EPO; the announcement of the new CERA (Mircera) test at the 2008 Tour de France was considered a major victory.

There are also dozens of “copycat” or “biosimilar” versions of EPO. These are variants of EPO that are produced by different methods or exist as slightly different biological forms of EPO e.g. darbepoetin alfa, epoetin alfa, epoetin beta, epoetin gamma, epoetin delta, epoetin epsilon, epoetin zeta, epoetin theta, epoetin kappa, epoetin omega. The existence of biosimilar versions of EPO is a major problem for drug testers (“Concerns over Olympic drug test,” July 21).

Because the medicine has been so successful financially, companies in India, China and Cuba have developed drugs that do a similar job in the body, but have a slightly different molecular fingerprint. These cheap versions of EPO, often called biosimilars, can be easily bought over the internet.

[…]

“There are now a number of compounds that bind to the EPO receptor, and there is no single test for them, you can order it here over the internet and it will be delivered to you here in the UK or in Germany; Chinese-made doping substances” [according to Professor Werner Franke].

Some scientists who track and monitor the development of copycat EPO drugs say there could be up to 80 different versions now being manufactured in different parts of the world.

A few biosimilar versions are available in the EU and Eastern Europe; however, a plethora of doping options are commercially available with biosimilar EPO pharmaceuticals produced around the world, particularly in Southeast Asia, several of which could be purchased inexpensively over the internet.

Abseamed (Medice Arzneimittel Pütter)
Aranesp (Amgen)
Binocrit (Sandoz)
Bioetin (Nanogenpharma) [Vietnam]
Ceriton (Rambaxy) [India]
Dynepo (Shire)
Epocim (CIMEQ) [Cuba]
Epoetin Alfa Hexal (Hexal Biotech Forschungs)
Epofer (Emcure) [India]
Epofit (INTAS Pharmaceuticals) [India]
Epogin (Chugai Pharmaceutical Company) [Japan]
Epokine (Macropharma Corporation) [Philippines]
Eporon (Century Pharmaceuticals) [India]
Eporon (Dong-A Pharmaceutical Company) [Korea]
Eposino (Shandong Kexing) [China]
Eposino (Hindustan Bio Sciences) [India]
Epotin (Claris Lifesciences) [India]
Epotrex-NP (Novell Pharmaceutical) [Indonesia],
Epoyet (Bio Sudis) [Argentina],
Eritina (Chalver Laboratories) [Columbia]
Eritrogen (Bioprofarma) [Argentina]
Eritromax (Blausiegel ) [Brazil],
Erykine (INTAS Pharmaceuticals) [India]
Erypo (Janssen-Cilag)
Espo (Kirin Brewery Company, Pharmaceutical Division) [Japan]
Espogen (Hoffman Health) [Pakistan]
Gerepo (North China Pharmaceutical Group Corporation) [Malaysia]
Hemapo (Innogene Kalbiotech) [Singapore]
Hemax (Seignior Pharma) [Pakistan]
Hypercrit (Biogalenic) [Venezuela]
Mircera (Roche)
NeoRecormon (Roche)
PDpoetin (Pooyesh Darou Pharmaceuticals) [Iran]
Renoge (Biomedis) [Philippines]
Retacrit (Hospira/STADA) [Germany]
Shanpoietin (Shanta Biotechnics) [India]
Silapo (Bioceuticals Arzneimittel AG)
Vintor (Emcure) [India]
Wepox (Wockhardt) [India]
Zyrop (Zydus Biogenyc) [India]

I think the science director of WADA could be considered delusional in his claim that WADA is catching all users of recombinant EPO.

Dr Olivier Rabin is WADA’s science director. Is he happy that the test is catching all the drug cheats?

“I am reasonably confident, yes,” he told the BBC. “Now, it would be very presumptuous on my part to say that we are absolutely 100% sure we are going to get everyone. But I can assure you that if you were to take recombinant EPO and that would be in your urine – then, yes, we would detect it.“

Maybe the public will buy it, but the athletes already know better.

Hat tip to Trust But Verify.

Tour de France doping - anabolic steroids, erythropoietin (EPO) and testosterone
Tour de France doping – anabolic steroids, erythropoietin (EPO) and testosterone
Epogen - Erythropoietin EPO
Epogen – Erythropoietin EPO

About the author

Millard
Millard
MESO-Rx | Website

Millard writes about anabolic steroids and performance enhancing drugs and their use and impact in sport and society. He discusses the medical and non-medical uses of anabolic-androgenic steroids while advocating a harm reduction approach to steroid education.

Filed Under: Steroid News Tagged With: EPO, epogen, mircera

Reader Interactions

Leave a Reply Cancel reply

You must be logged in to post a comment.

Primary Sidebar

Sponsors

Popular Articles

Masteron (dromostanolone) Alpha Pharma Mastebolin

How to Use Masteron

Masteron (dromostanolone propionate, also known as drostanolone propionate) had formerly been a rare drug in the United States and was enjoyed principally by our European friends. This was due to never been produced … [Read More...] about How to Use Masteron

Brain on steroids

Psychological and Behavioural Effects of Endogenous Testosterone Levels and Anabolic-Androgenic Steroids Among Males: A Review, Part 9

9. Discussion of Major Methodological Issues in Anabolic Steroid Research As noted previously, any attempt to evaluate and summarise the psychological and behavioural effects associated with the use of … [Read More...] about Psychological and Behavioural Effects of Endogenous Testosterone Levels and Anabolic-Androgenic Steroids Among Males: A Review, Part 9

Analytical Laboratory Testing for the Identification of Anabolic Steroids

Analytical Laboratory Testing for the Identification of Anabolic Steroids

Q: “I'm considering using an analytical lab for steroid testing. I see there are various kinds of test like HPLC-UV and GC/MS. Can you tell me about them, and which should I use?” A: In contrast to colorimetric … [Read More...] about Analytical Laboratory Testing for the Identification of Anabolic Steroids

How Much Mass Gains Can Be Expected in a Steroid Cycle?

How Much Mass Gains Can Be Expected in a Steroid Cycle?

Q: “How much mass gains can be expected in a steroid cycle? Obviously later cycles won't yield as much as the first cycle, but overall how does it work?” A: In a first cycle, retained muscle gains can be as high … [Read More...] about How Much Mass Gains Can Be Expected in a Steroid Cycle?

Gynecomastia

Gynecomastia: What the Literature Says About Prevalence and Hormonal Causes

Sex hormones play a pivotal role in the development of gynecomastia: the benign enlargement of breast tissue in men. It is an esthetically unpleasant side effect which might result from anabolic steroid use. It is … [Read More...] about Gynecomastia: What the Literature Says About Prevalence and Hormonal Causes

Footer

MESO-Rx International

MESO-Rx articles are also available in the following languages:

Deutsch, English, Español, Français, Português, Русский

Questions? Comments?

Use the following link to send us an e-mail. We will respond as soon as we can.

Contact us.

Search

Copyright © 1997–2025 MESO-Rx. All rights reserved. Disclaimer.